NCT07836374

Brief Summary

The researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have axial spondyloarthritis (axSpA). There are 3 main reasons the researchers are doing this study: 1) to test how easy it is for people with spondyloarthritis to use the RENEW program; 2) to assess whether people like the RENEW program and 3) to understand if it helps with symptom management and disease burden.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Sep 2026May 2027

Study Start

First participant enrolled

September 1, 2026

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 23, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 17, 2026

Last Update Submit

September 17, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • attendance at peer health coaching sessions among RENEW intervention participants.

    Assessed using the Goal Attainment Scaling (GAS) method, which measures the extent to which participants achieved their individualized goals

    across the 12-week period

  • Goal Attainment Scaling (GAS)

    Assessed by health coach

    Weeks 0, 6, 12

  • Theoretical Framework of Acceptability (TFA) score (RENEW Intervention group)

    12-item measure assessing affective attitude, burden, perceived effectiveness, and self-efficacy. An average of item scores \>4 out of 5 has been established as indicating high acceptability.

    Week 12

  • Qualitative Interviews (n=10-15 of RENEW Intervention group)

    Acceptability will also be assessed through qualitative interviews with a subset of intervention participants.

    Week 12

Study Arms (2)

Group 1: RENEW Program

EXPERIMENTAL

Participants placed in this group will be assigned a peer health coach to help guide them through the RENEW program right away. Peer health coaches are people on the study team with spondyloarthritis. In addition, approximately 10 to 15 people from this group will be invited to take part in an optional 30-minute interview after the program ends, to share feedback about their experience with RENEW. If invited, participating in this interview is entirely voluntary.

Other: RENEW

Group 2: Waitlist Group

NO INTERVENTION

If placed in this group, participants will receive access to the RENEW website at the end of the 12-week study period. At the end of the 12 weeks, participants will be offered the option to have 1 peer health coaching session with a peer health coach.

Interventions

RENEWOTHER

RENEW is a 12-week, peer-led, web-based program to help people with spondyloarthritis learn skills that can be used to manage disease symptoms and improve well-being. It includes: A website that includes information, worksheets, tools, and information from other people with spondyloarthritis 9 calls with a peer health coach, beginning with weekly calls for the first 6 weeks, and every other week for the last 6 weeks of the program. We will use telehealth platforms (like Zoom) for these calls. We will record them so we can track how well the peer health coaches are following the program. Each call will last no more than 30 minutes.

Group 1: RENEW Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physician-diagnosed axSpA (including non-radiographic axSpA)
  • Have moderate to severe fatigue (average of ≥4/7 on the Fatigue Severity Scale)
  • Access to a computer, tablet, or smartphone with internet connection
  • Ability to speak and read English
  • Willingness to participate in virtual Zoom coaching sessions and complete online assessments
  • Interested in making some changes and trying new ways to improve health and well-being

You may not qualify if:

  • Currently enrolled in other clinical trials
  • Currently undergoing structured rehabilitation or psychological treatment for major depressive disorder
  • Significant cognitive impairment that would prevent informed consent or participation
  • Severe psychiatric illness that would contraindicate participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Axial Spondyloarthritis

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Study Officials

  • Susan Murphy, ScD, OTR

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Yen Chen, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Haro

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This is a single-center, randomized controlled pilot trial with a 1:1 allocation ratio comparing the RENEW intervention group to a waitlist control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 17, 2026

First Posted

September 23, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations